Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

AbCellera

AbCellera Q3 earnings beat analyst estimates

AbCellera Biologics reported third-quarter revenue of $10.639 million, exceeding the $8.416 million estimate. The company also posted an adjusted loss per share of $0.13, better than the expected $0.16.

ABCL-5.0%

Illustration for the Business desk

The stocks in this story

  1. ABCL-5.0%AbCellera$10.47

Prices from Based on Thu, Nov 19 close · Opens Fri 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.